Physiotherapist assisting a patient with Amyotrophic Lateral Sclerosis.
After 12 years of research, Dr. Richard Robitaille is hopeful that we’ll soon have a treatment to help people with amyotrophic lateral sclerosis (ALS) regain mobility.
A new clinical trial is set to start soon, thanks to a $1-million grant from the American ALS Association announced just before Christmas. “I’m still in shock! For me, this grant is recognition of years of hard work,” said Robitaille, a full professor in the Department of Neurosciences in the University of Montreal’s Faculty of Medicine. “Now we will be able to run clinical trials on patients with ALS and ultimately use what we learn to help others suffering from the disease.”
